Overview

Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis

Status:
Completed
Trial end date:
2018-02-23
Target enrollment:
Participant gender:
Summary
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
Phase:
Phase 2
Details
Lead Sponsor:
Menlo Therapeutics Inc.
Vyne Therapeutics Inc.
Treatments:
Serlopitant